📰 Formulation Research News
Formulation Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Formulation Research. Real-time updates on events, politics, business and more.
October 22, 2021
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
October 22, 2021
I-Mab is establishing a new site in San Diego that will focus on translational medicine and formulation research.
April 13, 2021
molecules ‒ known as PROTAC® (PROteolysis TArgeting Chimeras) 8210; aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews , Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. The proprietary PROTAC® -based drug paradigm induces protein degradation, rather than protein inhibition...